Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michal Lotem

Showing results (51-60 of 93) with videos related to

Pageof 10
Sort By:
Medchemcomm|July 4, 2017
Phenotype-based variation as a biomarker of sensitivity to molecularly targeted therapy in melanomaKerem M Senses, Mehdi Ghasemi, Muhammad W Akbar, et al.
Science Translational Medicine|June 7, 2023
Preventing skin toxicities induced by EGFR inhibitors by topically blocking drug-receptor interactionsNethanel Friedman, Liza Weinstein-Fudim, Yelena Mostinski, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 9, 2002
CD66a interactions between human melanoma and NK cells: a novel class I MHC-independent inhibitory mechanism of cytotoxicityGal Markel, Niva Lieberman, Gil Katz, et al.
Cancer Immunology Research|January 7, 2018
Soluble SLAMF6 Receptor Induces Strong CD8<sup>+</sup> T-cell Effector Function and Improves Anti-Melanoma Activity <i>In Vivo</i>Galit Eisenberg, Roni Engelstein, Anat Geiger-Maor, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 30, 2018
Combined Expression of Genetic Adjuvants Via mRNA Electroporation Exerts Multiple Immunostimulatory Effects on Antitumor T CellsHadas Weinstein-Marom, Noam Levin, Aviad Pato, et al.
ACS Medicinal Chemistry Letters|May 22, 2020
Predictive Gene Signature for Pyrazolopyrimidine Derivative c-Src Inhibitor 10a Sensitivity in Melanoma CellsBaris Kucukkaraduman, Can Turk, Anna L Fallacara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 16, 2009
Autologous melanoma vaccine induces antitumor and self-reactive immune responses that affect patient survival and depend on MHC class II expression on vaccine cellsMichal Lotem, Arthur Machlenkin, Tamar Hamburger, et al.
Cancer Reports (Hoboken, N.J.)|September 26, 2023
Tumor-infiltrating lymphocyte transfusion in a patient with treatment refractory triple negative breast cancerArielle Jacover, Yonaton Zarbiv, Keidar Haran Tal, et al.
Frontiers in Oncology|March 3, 2020
Immunotherapy Potentiates the Effect of Chemotherapy in Metastatic Melanoma-A Retrospective StudyReut Hadash-Bengad, Emma Hajaj, Shiri Klein, et al.
Immunologic Research|July 22, 2022
The role of immune checkpoint receptors in the malignant phenotype of cutaneous T cell lymphomaRony Shreberk-Hassidim, Anat Geiger-Maor, Galit Eisenberg, et al.
Pageof 10

Showing results (51-60 of 93) with videos related to

Sort By:
Pageof 10
Medchemcomm|July 4, 2017
Phenotype-based variation as a biomarker of sensitivity to molecularly targeted therapy in melanomaKerem M Senses, Mehdi Ghasemi, Muhammad W Akbar, et al.
Science Translational Medicine|June 7, 2023
Preventing skin toxicities induced by EGFR inhibitors by topically blocking drug-receptor interactionsNethanel Friedman, Liza Weinstein-Fudim, Yelena Mostinski, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 9, 2002
CD66a interactions between human melanoma and NK cells: a novel class I MHC-independent inhibitory mechanism of cytotoxicityGal Markel, Niva Lieberman, Gil Katz, et al.
Cancer Immunology Research|January 7, 2018
Soluble SLAMF6 Receptor Induces Strong CD8<sup>+</sup> T-cell Effector Function and Improves Anti-Melanoma Activity <i>In Vivo</i>Galit Eisenberg, Roni Engelstein, Anat Geiger-Maor, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 30, 2018
Combined Expression of Genetic Adjuvants Via mRNA Electroporation Exerts Multiple Immunostimulatory Effects on Antitumor T CellsHadas Weinstein-Marom, Noam Levin, Aviad Pato, et al.
ACS Medicinal Chemistry Letters|May 22, 2020
Predictive Gene Signature for Pyrazolopyrimidine Derivative c-Src Inhibitor 10a Sensitivity in Melanoma CellsBaris Kucukkaraduman, Can Turk, Anna L Fallacara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 16, 2009
Autologous melanoma vaccine induces antitumor and self-reactive immune responses that affect patient survival and depend on MHC class II expression on vaccine cellsMichal Lotem, Arthur Machlenkin, Tamar Hamburger, et al.
Cancer Reports (Hoboken, N.J.)|September 26, 2023
Tumor-infiltrating lymphocyte transfusion in a patient with treatment refractory triple negative breast cancerArielle Jacover, Yonaton Zarbiv, Keidar Haran Tal, et al.
Frontiers in Oncology|March 3, 2020
Immunotherapy Potentiates the Effect of Chemotherapy in Metastatic Melanoma-A Retrospective StudyReut Hadash-Bengad, Emma Hajaj, Shiri Klein, et al.
Immunologic Research|July 22, 2022
The role of immune checkpoint receptors in the malignant phenotype of cutaneous T cell lymphomaRony Shreberk-Hassidim, Anat Geiger-Maor, Galit Eisenberg, et al.
Pageof 10